These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 2466578
21. In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle. Moro S, Ferreiro M, Celestino D, Medei E, Elizari MV, Sicouri S. J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):314-21. PubMed ID: 18172226 [Abstract] [Full Text] [Related]
22. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide. Annesley T, Matz K, Davenport R, Giacherio D. Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377 [Abstract] [Full Text] [Related]
24. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide. Vlasses PH, Kosoglou T, Chase SL, Greenspon AJ, Lottes S, Andress E, Ferguson RK, Rocci ML. Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472 [Abstract] [Full Text] [Related]
25. Recordings of the local pacing-induced myocardial activation and repolarization. Donaldson RM, Taggart P, Nashat F, Rickards AF. Jpn Heart J; 1984 Jan; 25(1):19-29. PubMed ID: 6737697 [Abstract] [Full Text] [Related]
26. Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording. Sugiyama A, Ni C, Arita J, Eto K, Xue YX, Hashimoto K. Toxicol Appl Pharmacol; 1996 Jul; 139(1):109-14. PubMed ID: 8685892 [Abstract] [Full Text] [Related]
27. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers. Nattel S. J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790 [Abstract] [Full Text] [Related]
28. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma. Raphanaud D, Borensztejn M, Dupeyron JP, Guyon F. Ther Drug Monit; 1986 Apr; 8(3):365-7. PubMed ID: 2428144 [Abstract] [Full Text] [Related]
29. Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes. Dohrmann ML, Goldschlager NF. Cardiol Clin; 1985 Nov; 3(4):527-37. PubMed ID: 3910236 [Abstract] [Full Text] [Related]
30. Molecular basis of the different effects of procainamide and N-acetylprocainamide on the maximum upstroke velocity and half-decay time of the cardiac action potential in guinea pig papillary muscle. Sigler W, Oliveira AC. Braz J Med Biol Res; 2023 Nov; 56():e12073. PubMed ID: 36722655 [Abstract] [Full Text] [Related]
34. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow]. Kusowska J, Polakowski P. Acta Pol Pharm; 1989 Nov; 46(2):187-94. PubMed ID: 2483600 [Abstract] [Full Text] [Related]
36. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide. vasBinder E, Annesley T. Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575 [Abstract] [Full Text] [Related]
37. Effects of procainamide on transmural ventricular repolarisation. Wang L, Yong AC, Kilpatrick D. Cardiovasc Drugs Ther; 2002 Jul; 16(4):335-9. PubMed ID: 12652103 [Abstract] [Full Text] [Related]
38. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ. Amlie JP, Landmark K. Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356 [Abstract] [Full Text] [Related]